MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.330
-0.120 (-8.28%)
At close: Dec 30, 2025, 4:00 PM EST
1.350
+0.020 (1.50%)
Pre-market: Dec 31, 2025, 4:01 AM EST
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $49.25 million as of December 31, 2025. Its market cap has decreased by -6.07% in one year.
Market Cap
49.25M
Enterprise Value
38.36M
1-Year Change
-6.07%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has decreased from $51.10M to $49.25M, a decrease of -3.62%. That is a compound annual growth rate of -1.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 53.70M | 3.68% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.70B |
| Johnson & Johnson | 499.33B |
| AbbVie | 405.63B |
| UnitedHealth Group | 302.00B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 263.59B |
| Novo Nordisk | 229.27B |